Is Hba1C a poor yardstick for determining access to new T1D treatments in the real world
If you’ve ever looked at a clinical trials document for a type 1 treatment, you’ll nearly always spot two things. Reduction in Hba1C is a […]
Closed Loop
Smart Insulin and “Artificial Pancreases” – what lessons can the latter give the former?
The JDRF has spent a lot of effort and money on projects that address both Smart Insulin and Artificial Pancreases. Most of us are very familiar […]
Port and Portability – some further thoughts. A truly portable, offline instance of #OpenAPS
Late last year, I wrote about form and physicality of the hybrid closed loop, bemoaning the stuff I was carrying, and a few other things. […]
#Loop and #OpenAPS – living with both, the similarities and differences – let’s get down and dirty…
This post has now been superseded by an updated page on this website that can be found here: http://www.diabettech.com/looping-a-guide/comparing-the-loop-and-openaps-algorithms/
The benefit of freedom from a Hybrid Closed #Loop or #OpenAPS… #wearenotwaiting
Having now run a combination of OpenAPS and Loop for a full month, I thought it was about time to publish some data from looping, […]
Looping. Do I choose #OpenAPS or #Loop? Either way #wearenotwaiting!
***UPDATED 8th February 2017 to include portability options from OpenAPS with Edison and Explorer board*** Okay, you’ve looked at the looping options, and you know […]
The loss of a #loop. Recognising the “Life” benefits of hybrid closed loop systems.
A day without a loop – it feels like an eternity. As crazy as it seems. But why? Well let’s start at the beginning, and […]
Comparing @OpenAPS and the Medtronic Hybrid Closed Loop System – what does the data say?
With the release yesterday of the Medtronic Hybrid Closed Loop pivotal study data, I thought it would be interesting to take a look at the […]